[1]
Farzona Aripdzhanova tran. 2026. CLINICAL COURSE AND TREATMENT CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE. Uzbekistan Open Conference. 11 (Apr. 2026).